ClassID:

117378

C12Y306/03009 - CPC Classification

Classification description:

Hydrolases acting on acid anhydrides (3.6) acting on acid anhydrides; catalysing transmembrane movement of substances (3.6.3) Na+/K+-exchanging ATPase (3.6.3.9)

Recent Application in this class:
#1
20200157568
2020-05-21

EXPRESSION VECTORS AND RELATED METHODS OF DELIVERY OF Na/K ATPASE/Src RECEPTOR COMPLEX ANTAGONISTS

#2
20200116726
2020-04-16

PANCREATIC CANCER TARGETS AND USES THEREOF

#3
20200030404
2020-01-30

Compositions and methods for treating retinopathy

#4
20180353569
2018-12-13

Methods for treating obesity

#5
20170219591
2017-08-03

PANCREATIC CANCER TARGETS AND USES THEREOF

#6
20170183639
2017-06-29

Cardiotonic steroid antagonists and related methods

#7
20160355607
2016-12-08

Activation of (NA+K)-ATPase inhibits platelet aggregation and prevents thrombosis

#8
20150355177
2015-12-10

Diagnosis of a neurological disease

#9
20150133389
2015-05-14

Methods of treatment of cancer using SRC-modulating peptides

#10
20130150294
2013-06-13

Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases

#11
20120128677
2012-05-24

Pancreatic cancer targets and uses thereof

#12
20110124708
2011-05-26

RNAI-MEDIATED INHIBITION OF OCULAR HYPERTENSION TARGETS

#13
20100190169
2010-07-29

SINGLE NUCLEOTIDE POLYMORPHISMS PREDICTING CARDIOVASCULAR DISEASE

#14
20100068198
2010-03-18

TARGETING OF ALPHA-1 OR ALPHA-3 SUBUNIT OF NA+, K+-ATPASE IN THE TREATMENT OF PROLIFERATIVE DISEASES

#15
20100056446
2010-03-04

Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases

#16
20090326044
2009-12-31

RNAi-Mediated Inhibition of Ocular Targets

#17
20090138977
2009-05-28

Pancreatic cancer targets and uses thereof

#18
20080199895
2008-08-21

Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same

#19
20070202506
2007-08-30

Single nucleotide polymorphisms predicting cardiovascular disease

#20
20060172965
2006-08-03

RNAi-mediated inhibition of ocular targets

#21
20060172963
2006-08-03

RNAi-mediated inhibition of ocular hypertension targets